The Comparison of the Effects of Nebivolol and Metoprolol on Erectile Dysfunction in the Cases with Coronary Artery Bypass Surgery

Basit Öğe Kaydı
dc.authorscopusid10139012600
dc.authorscopusid14008084500
dc.authorscopusid23391660500
dc.authorscopusid23052928300
dc.authorwosidgur, ozcan/AAA-8847-2022
dc.authorwosidGurkan, Selami/AAA-9006-2022
dc.contributor.authorGür, Özcan
dc.contributor.authorGürkan, Selami
dc.contributor.authorYümün, Gündüz
dc.contributor.authorTürker, Polat
dc.date.accessioned2022-05-11T14:12:32Z
dc.date.available2022-05-11T14:12:32Z
dc.date.issued2017
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Beyin ve Sinir Cerrahisi Ana Bilim Dalı
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalı
dc.description.abstractPurpose: Beta-blocker use is common in the cases with coronary artery bypass surgery. According to the literature, beta-blockers have positive effects but may cause erectile dysfunction (ED). The most commonly used beta-blockers in ischemic cardiac disease are nebivolol and metoprolol. In our clinic, we aimed to compare the effects of nebivolol and metoprolol succinate on ED in the sexually active cases with coronary artery bypass surgery. Methods: In our clinic, a total of 119 patients with coronary artery bypass surgery were included in the study. International Index of Erectile Function (IIEF-5) Test was used to evaluate whether the patients had ED and to grade the cases. Results: No significant difference was found in terms of anti-ischemic efficacy between metoprolol succinate and nebivolol in the postoperative period; however, the incidence of any grade ED was % 85.96 in Group 1, % 83.87 in Group 2. This difference was considered as statistically significant (p = 0.036). Conclusion: Beta-blocker use increases the risk of ED in cases with ischemic cardiac disease. We suggest that the complaints of ED could be less frequent with nebivolol use in sexually active cases with ischemic cardiac disease.
dc.description.sponsorshipNamik Kemal UniversityNamik Kemal University
dc.description.sponsorshipNamik Kemal University provided financial support for the study as a scientific research project.
dc.identifier.doi10.5761/atcs.oa.16-00242
dc.identifier.endpage95
dc.identifier.issn1341-1098
dc.identifier.issn2186-1005
dc.identifier.issue2en_US
dc.identifier.pmid28302931
dc.identifier.scopus2-s2.0-85018802686
dc.identifier.scopusqualityQ2
dc.identifier.startpage91
dc.identifier.urihttps://doi.org/10.5761/atcs.oa.16-00242
dc.identifier.urihttps://hdl.handle.net/20.500.11776/5590
dc.identifier.volume23
dc.identifier.wosWOS:000401002500005
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorGür, Özcan
dc.institutionauthorGürkan, Selami
dc.institutionauthorYümün, Gündüz
dc.institutionauthorTürker, Polat
dc.language.isoen
dc.publisherMedical Tribune Inc
dc.relation.ispartofAnnals of Thoracic and Cardiovascular Surgery
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectcoronary artery bypass surgery
dc.subjectbeta-blocker
dc.subjecterectile dysfunction
dc.subjectBeta-Blockers
dc.subjectEssential-Hypertension
dc.subjectNitric-Oxide
dc.subjectDouble-Blind
dc.subjectAtenolol
dc.subjectTherapy
dc.subjectDisease
dc.titleThe Comparison of the Effects of Nebivolol and Metoprolol on Erectile Dysfunction in the Cases with Coronary Artery Bypass Surgery
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
5590.pdf
Boyut:
89.03 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
Tıp Fakültesi Koleksiyonu